Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
(2021) 6:e141299
[] MAPK1, the other core target identified in this study, is responsible for the proliferation and survival of epithelial cells
KEY FEATURES High-purity BPC-157 research peptide 5mg lyophilised powder per vial HPLC-MS verified purity (99.67%) Manufactured in accredited laboratories Sterile, tamper-evident vial suitable for laboratory handling Fast, discreet Australia-wide shipping SPECIFICATIONS Product Name BPC-157 Peptide Grade Research Grade Quantity 5mg per vial Form Lyophilised powder Purity 99.67% (HPLC-MS tested) Appearance White/off-white lyophilised powder Storage Conditions Cool, dry environment
Certificate of Analysis & Safety Data What researchers are saying Fighting some knee pain
Further investigations and large-scale clinical trials need to confirm its effects and safety in humans